Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neuronetics Inc
NRCCurrent price
0.66 EUR
+0.028 EUR (+4.47%)
Last closed
0.95 USD
Company
www.neurostar.com
ISIN
US64131A1051
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Frankfurt Exchange
Capitalization
22 146 010 USD
Yield for 12 month
-30.01 %
1Y
3Y
5Y
10Y
15Y
NRC
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Address: 3222 Phoenixville Pike, Malvern, PA, United States, 19355
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.33 USDP/E ratio
–Dividend Yield
–Current Year
+71 348 000 USD
Last Year
+65 206 000 USD
Current Quarter
+16 450 000 USD
Last Quarter
+17 417 000 USD
Current Year
+49 699 000 USD
Last Year
+49 723 000 USD
Current Quarter
+11 624 000 USD
Last Quarter
+12 528 000 USD
Key Figures NRC
1 year
3 years
5 years
10 years
EBITDA
-24 646 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-16.9 %
PEG Ratio
–
Return On Equity TTM
-100.13 %
Wall Street Target Price
3.33 USD
Revenue TTM
72 065 000 USD
Book Value
0.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-6.6 %
Dividend Yield
–
Gross Profit TTM
49 723 000 USD
Earnings per share
-1.1 USD
Diluted Eps TTM
-1.1 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-45.06 %
Dividend Analytics NRC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NRC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NRC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.5751
Price Sales TTM
0.3073
Enterprise Value EBITDA
-2.0218
Price Book MRQ
1.1424
Financials NRC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NRC
For 52 weeks
0.66 USD
5.07 USD
50 Day MA
1.39 USD
Shares Short Prior Month
663 952
200 Day MA
2.61 USD
Short Ratio
0.81
Shares Short
555 332
Short Percent
1.94 %
BeatStart